Newsmax Magazine: New Approach to Cancer Treatment

08/06/2024

A new type of cancer drug could transform the treatment for many deadly cancers, especially those that have advanced or metastasized and do not respond to other therapies.

Rather than killing cancer cells, as chemotherapy does, the new drug – now being studied by the Cleveland Clinic in Ohio – aims to trigger one of our main natural defenses.

CLICK HERE to read the full story from Newsmax Magazine.

READ MORE

06/06/2025

Crain’s Cleveland Business: Cleveland biotech company secures $2.7M in NIH funding

Lamassu Biotech, a company with its “second headquarters” in Cleveland, has received a $2.7 million grant from the National Institutes of Health (NIH). The funds will help support the development of a novel treatment protocol for acute pancreatitis in canines....

READ THE ARTICLE
06/04/2025

Cleveland Business Journal: Lamassu Biotech’s dog treatment could lead to human pancreatitis breakthrough, backed by NIH funds

Lamassu Biotech, the North Carolina-based biopharmaceutical company that opened a Cleveland office last year, has received a $2.7 million grant from the National Institutes of Health to help develop its therapy for dogs with acute pancreatitis. The therapeutic, called RABI-767, also could...

READ THE ARTICLE
04/08/2025

The Washington Times: Biotech should take a page from Elon Musk’s playbookThe Washington Post:

Innovation has always been the foundation of progress, but how we innovate matters as much as the results we achieve. Recent breakthroughs in aerospace and artificial intelligence prove that massive budgets don’t drive innovation, but efficiency, speed and a relentless...

READ THE ARTICLE